Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
| Author | |
|---|---|
| Abstract | :
Few data exist regarding use of nucleos(t)ide analogs started in early pregnancy for mothers with active chronic hepatitis B (CHB). We assessed the safety and efficacy of lamivudine/telbivudine initiated in the first trimester versus no treatment in mothers with active CHB. |
| Year of Publication | :
2018
|
| Journal | :
Hepatology international
|
| Date Published | :
2018
|
| ISSN Number | :
1936-0533
|
| URL | :
https://dx.doi.org/10.1007/s12072-017-9839-5
|
| DOI | :
10.1007/s12072-017-9839-5
|
| Short Title | :
Hepatol Int
|
| Download citation |